Caribou Biosciences, Inc. Common Stock (CRBU) is a publicly traded Healthcare sector company. As of May 21, 2026, CRBU trades at $2.01 with a market cap of $205.30M and a P/E ratio of -1.24. CRBU moved +0.76% today. Year to date, CRBU is +24.22%; over the trailing twelve months it is +81.82%. Its 52-week range spans $0.66 to $3.54. Analyst consensus is strong buy with an average price target of $9.00. Rallies surfaces CRBU's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CRBU combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.01 |
| Market Cap | $205.30M |
| P/E Ratio | -1.24 |
| EPS | $-1.59 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.54 |
| 52-Week Low | $0.66 |
| Volume | 167 |
| Avg Volume | 0 |
| Revenue (TTM) | $11.16M |
| Net Income | $-148.13M |
| Gross Margin | 0.00% |
8 analysts cover CRBU: 0 strong buy, 8 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $9.00.